You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TCR-engineered T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

Recruiting
  • Melanoma
  • +2 more
  • Adoptive therapy with autologous MC2 TCR T cells
  • Rotterdam, Netherlands
    Erasmus Medical Center
Jun 1, 2022

HLA Typing and Tumor Neoantigen Identification forPhase I/II

Recruiting
  • Ovarian Cancer
  • +5 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

    Recruiting
    • Gynecologic Cancer
    • +11 more
    • Neoantigen specific TCR-T cell drug product
    • Aldesleukin (IL-2)
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Hepatocellular Carcinoma Trial in Beijing, Shanghai, Shenyang (SCG101, PD1/PD-L1 checkpoint inhibitor)

    Recruiting
    • Hepatocellular Carcinoma
    • SCG101
    • PD1/PD-L1 checkpoint inhibitor
    • Beijing, China
    • +3 more
    May 7, 2022

    Solid Tumor, Cancer, Recurrent Solid Tumors Trial in Germany, United States (IMA201 Product, IMADetect®)

    Recruiting
    • Solid Tumor
    • +3 more
    • IMA201 Product
    • IMADetect®
    • Chicago, Illinois
    • +6 more
    Dec 28, 2021

    Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial (PACE CART19)

    Withdrawn
    • Acute Lymphoblastic Leukemia
    • +2 more
    • PACE CART19
    • (no location specified)
    Mar 9, 2022

    Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,

    Recruiting
    • Endocrine/Neuroendocrine
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in

    Suspended
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 23, 2022

    Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

    Not yet recruiting
    • Head and Neck Cancer
    • +20 more
    • TSC-204-A0201
    • +4 more
    • Scottsdale, Arizona
    • +1 more
    Aug 3, 2023

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

    Active, not recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Aldesleukin
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 3, 2022

    Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

    Not yet recruiting
    • Myeloma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2023

    Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

    Recruiting
    • Cervical Carcinoma
    • TC-E202 cells
    • +3 more
    • Chongqing, Chongqing, China
      Xiaochun Cheng
    Oct 20, 2022

    Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)

    Recruiting
    • Advanced Solid Tumors
    • TC-N201 cells
    • +4 more
    • Chongqing, China
      TCRCure Biopharma Ltd.
    May 25, 2023

    EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV Infection After Allogenic HSCT
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 3, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

    Recruiting
    • Pancreatic Cancer
    • TCR-T Cells Injection（GB3010 Cells Injection）
    • ShangHai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
    Sep 19, 2023

    Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

    Active, not recruiting
    • Malignant Neoplasm
    • aldesleukin
    • +7 more
    • Los Angeles, California
      University of California at Los Angeles (UCLA )
    Dec 1, 2022

    EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV-associated Hemophagocytic Lymphohistiocytosis
    • EBV Infection
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 12, 2023

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023